IP Verse

Anti-Cd20 Antibody

Patent No. EP3507369 (titled "Anti-Cd20 Antibody") was filed by Beijing Mabworks Biotech on Aug 28, 2017. The application was issued on Jun 12, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ARROWHOUSEMar 12, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
KAROMar 11, 2025-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3507369

BEIJING MABWORKS BIOTECH
Application Number
EP17845369A
Filing Date
Aug 28, 2017
Status
Granted And Under Opposition
May 10, 2024
Publication Date
Jun 12, 2024
External Links
Slate, EP3507369B1, Google Patents